Abstract
Advances in genetic engineering and genomic studies facilitated the development of animal models of human diseases. To date, numerous models based on different animal species are available for the most socially significant human diseases, such as cardiovascular disorders, cancer, neurodegenerative and metabolic disorders. Modern genetic methods allow creating animals with certain genes up- or downregulated, as well as bearing specific mutations. However, this precision is not easy to translate into clinical practice: animal models still have their limitations, including both physiological and genetic differences between humans and animals and complexity of disease conditions that are difficult to reproduce. In this review, we will discuss the most relevant modern techniques that allow creating genetically engineered animal models.
Keywords: Gene editing, genetic engineering, animal model, CRISPR, human disease, Chromosome 1.
Current Molecular Medicine
Title:Human Disease Modelling Techniques: Current Progress
Volume: 18 Issue: 10
Author(s): Victor Yu. Glanz, Alexander N. Orekhov*Alexey V. Deykin
Affiliation:
- Institute of Gene Biology, Russian Academy of Sciences, Moscow,Russian Federation
Keywords: Gene editing, genetic engineering, animal model, CRISPR, human disease, Chromosome 1.
Abstract: Advances in genetic engineering and genomic studies facilitated the development of animal models of human diseases. To date, numerous models based on different animal species are available for the most socially significant human diseases, such as cardiovascular disorders, cancer, neurodegenerative and metabolic disorders. Modern genetic methods allow creating animals with certain genes up- or downregulated, as well as bearing specific mutations. However, this precision is not easy to translate into clinical practice: animal models still have their limitations, including both physiological and genetic differences between humans and animals and complexity of disease conditions that are difficult to reproduce. In this review, we will discuss the most relevant modern techniques that allow creating genetically engineered animal models.
Export Options
About this article
Cite this article as:
Glanz Yu. Victor , Orekhov N. Alexander *, Deykin V. Alexey , Human Disease Modelling Techniques: Current Progress, Current Molecular Medicine 2018; 18 (10) . https://dx.doi.org/10.2174/1566524019666190206204357
DOI https://dx.doi.org/10.2174/1566524019666190206204357 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Cancer Cytotoxic Effects of Multiwalled Carbon Nanotubes
Current Pharmaceutical Design Serum MicroRNA-21 as a Biomarker for Allergic Inflammatory Disease in Children
MicroRNA Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing
Current Medicinal Chemistry Endoplasmic Reticulum Stress in Chronic Obstructive Lung Diseases
Current Molecular Medicine Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Unusual Clinical Manifestations of the Antiphospholipid Syndrome
Current Rheumatology Reviews Cancer and Treatment Modalities
Current Cancer Therapy Reviews Anti-MDR Effects of Quercetin and its Nanoemulsion in Multidrug-Resistant Human Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Current Pharmaceutical Design Thinking Outside the ‘Block’: Alternative Polymer Compositions for Micellar Drug Delivery
Current Topics in Medicinal Chemistry Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets Cancer Gene Therapy Utilizing Interleukin-13 Receptor α2 Chain
Current Gene Therapy Overview of Brain Tumor Stem Cells – Implications for Treatment
Current Signal Transduction Therapy The Emerging Diabetes Online Community
Current Diabetes Reviews Microarray Data Integration: Frameworks and a List of Underlying Issues
Current Bioinformatics Vascular Endothelial Growth Factor Receptor 1, a Therapeutic Target in Cancer, Inflammation and Other Disorders
Current Medicinal Chemistry Diosmetin Induces Apoptosis by Downregulating AKT Phosphorylation via P53 Activation in Human Renal Carcinoma ACHN Cells
Protein & Peptide Letters Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design
Mini-Reviews in Medicinal Chemistry A Brief Survey on Computational Approaches to Reveal Drug and Disease Associations
Current Drug Discovery Technologies Cellomics as Integrative Omics for Cancer
Current Proteomics